Debertin, Ortiz, Wigle, Shen, Saddoughi, Puig, Cassivi, Reisenauer, & Tapias (2026). The Additive Effect of High-Risk Tumor Features on Long-Term Survival and Recurrence in Pathologic Stage I NSCLC.. The Journal of thoracic and cardiovascular surgery.
Debertin, Ortiz, Wigle, Shen, Saddoughi, Puig, et al. The Additive Effect of High-Risk Tumor Features on Long-Term Survival and Recurrence in Pathologic Stage I NSCLC.. The Journal of thoracic and cardiovascular surgery. 2026; PMID: 42128133
Debertin, Ortiz, Wigle, et al. The Additive Effect of High-Risk Tumor Features on Long-Term Survival and Recurrence in Pathologic Stage I NSCLC.[J]. The Journal of thoracic and cardiovascular surgery. 2026.
@article{debertin2026,
author = {Debertin and Ortiz and Wigle and Shen and Saddoughi and Puig and Cassivi and Reisenauer and Tapias},
title = {The Additive Effect of High-Risk Tumor Features on Long-Term Survival and Recurrence in Pathologic Stage I NSCLC.},
journal = {The Journal of thoracic and cardiovascular surgery},
year = {2026},
note = {PMID: 42128133},
}
TY - JOUR AU - Debertin AU - Ortiz AU - Wigle AU - Shen AU - Saddoughi AU - Puig AU - Cassivi AU - Reisenauer AU - Tapias TI - The Additive Effect of High-Risk Tumor Features on Long-Term Survival and Recurrence in Pathologic Stage I NSCLC. T2 - The Journal of thoracic and cardiovascular surgery PY - 2026 AN - PMID:42128133 ER -
The standard of care for stage I non-small cell lung cancer (NSCLC) is curative-intent surgical resection without adjuvant therapy. However, many patients experience recurrence or death after surgery. This study aimed to assess the impact of high-risk tumor features in patients with stage I NSCLC.